Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 1
2000 1
2001 1
2003 1
2006 1
2008 1
2013 1
2014 1
2015 1
2016 3
2017 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.
Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JNG, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P. Hartmann K, et al. J Allergy Clin Immunol. 2016 Jan;137(1):35-45. doi: 10.1016/j.jaci.2015.08.034. Epub 2015 Oct 21. J Allergy Clin Immunol. 2016. PMID: 26476479 Review.
Clinical observations suggest that the monomorphic variant, if it develops in children, often persists into adulthood, whereas the polymorphic variant may resolve around puberty. This delineation might have important prognostic implications, and its implementation in diagn …
Clinical observations suggest that the monomorphic variant, if it develops in children, often persists into adulthood, whereas the polymorph …
Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Severino M, Chandesris MO, Barete S, Tournier E, Sans B, Laurent C, Apoil PA, Lamant L, Mailhol C, Laroche M, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C. Severino M, et al. J Am Acad Dermatol. 2016 May;74(5):885-91.e1. doi: 10.1016/j.jaad.2015.10.050. Epub 2016 Feb 19. J Am Acad Dermatol. 2016. PMID: 26899198
Telangiectasia Macularis Eruptiva Perstans of the Scalp Mimicking Angiosarcoma.
Lawrence M, Sampson J, Oliver F, Restall P, Mackenzie M. Lawrence M, et al. Am J Dermatopathol. 2021 Dec 1;43(12):e277-e279. doi: 10.1097/DAD.0000000000002070. Am J Dermatopathol. 2021. PMID: 34797809
Although also rare, in contrast to TMEP, cutaneous angiosarcoma is a highly malignant vascular tumor with a poor prognosis. This case highlights the importance of including TMEP on the differential diagnosis where vascular lesions of the scalp are observed....
Although also rare, in contrast to TMEP, cutaneous angiosarcoma is a highly malignant vascular tumor with a poor prognosis. This case …
Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.
Tumer G, Jow T, McElligott S, Schwartz RA, Lambert WC. Tumer G, et al. Skinmed. 2017 Jun 1;15(3):171-174. eCollection 2017. Skinmed. 2017. PMID: 28705275
One patient experienced only a localized skin manifestation, another an aggressive clinical course with systemic involvement, and a third diffuse skin involvement with mild fatigue, muscle pain, and weight gain....
One patient experienced only a localized skin manifestation, another an aggressive clinical course with systemic involvement, and a t …
Telangiectasia macularis eruptiva perstans.
Gibbs NF, Friedlander SF, Harpster EF. Gibbs NF, et al. Pediatr Dermatol. 2000 May-Jun;17(3):194-7. doi: 10.1046/j.1525-1470.2000.01750.x. Pediatr Dermatol. 2000. PMID: 10886750
The disorder is characterized by telangiectatic macules and generally has a good prognosis, with little tendency to urticate or cause constitutional symptoms. ...
The disorder is characterized by telangiectatic macules and generally has a good prognosis, with little tendency to urticate or cause …
Familial cutaneous mastocytosis.
Chang A, Tung RC, Schlesinger T, Bergfeld WF, Dijkstra J, Kahn TA. Chang A, et al. Pediatr Dermatol. 2001 Jul-Aug;18(4):271-6. doi: 10.1046/j.1525-1470.2001.01939.x. Pediatr Dermatol. 2001. PMID: 11576397 Review.
Cutaneous mastocytosis: a review focusing on the pediatric population.
Briley LD, Phillips CM. Briley LD, et al. Clin Pediatr (Phila). 2008 Oct;47(8):757-61. doi: 10.1177/0009922808318344. Epub 2008 May 23. Clin Pediatr (Phila). 2008. PMID: 18502981 Review.
The majority of pediatric cases of cutaneous mastocytosis show a good prognosis with gradual resolution of both symptoms and skin lesions. ...
The majority of pediatric cases of cutaneous mastocytosis show a good prognosis with gradual resolution of both symptoms and skin les …
Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
Pascual JC, Bañuls J, Albares MP, Vergara G, Belinchón I, Silvestre JF, Betlloch I. Pascual JC, et al. J Cutan Med Surg. 2003 Sep-Oct;7(5):399-402. doi: 10.1007/s10227-002-0144-z. Epub 2003 Sep 24. J Cutan Med Surg. 2003. PMID: 14973646
CONCLUSIONS: TMEP is a rare form of mastocytosis, which occurs mainly in adults, generally has a good prognosis, and little tendency to urticate or show constitutional symptoms. ...
CONCLUSIONS: TMEP is a rare form of mastocytosis, which occurs mainly in adults, generally has a good prognosis, and little tendency …
Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
Turchin I, Barankin B, Schloss E. Turchin I, et al. Int J Dermatol. 2006 Oct;45(10):1215-7. doi: 10.1111/j.1365-4632.2006.02648.x. Int J Dermatol. 2006. PMID: 17040445
This case highlights the cutaneous findings of mastocytosis with systemic involvement, yet the patient maintains a relatively normal lifestyle with only minimal discomfort and only borderline normochromic anemia. Thus his course is not truly that of malignant mastocytosis …
This case highlights the cutaneous findings of mastocytosis with systemic involvement, yet the patient maintains a relatively normal lifesty …
Prevalence and risk factors for fragility fracture in systemic mastocytosis.
Degboé Y, Eischen M, Nigon D, Apoil PA, Mailhol C, Tournier E, Laurent C, Hanssens K, Hermine O, Paul C, Laroche M, Bulai-Livideanu C. Degboé Y, et al. Bone. 2017 Dec;105:219-225. doi: 10.1016/j.bone.2017.09.005. Epub 2017 Sep 14. Bone. 2017. PMID: 28919366
CONCLUSIONS: Low femoral T-score, BMT level, and older age at diagnosis are markers associated with FF in SM. BMT may represent an important biomarker to predict FF in SM patients....
CONCLUSIONS: Low femoral T-score, BMT level, and older age at diagnosis are markers associated with FF in SM. BMT may represent an important …
15 results